Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $440.72 million. The enterprise value is $347.05 million.

Market Cap	440.72M
Enterprise Value	347.05M

Important Dates

The last earnings date was Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

BNTC has 33.86 million shares outstanding. The number of shares has increased by 59.78% in one year.

Current Share Class	33.86M
Shares Outstanding	33.86M
Shares Change (YoY)	+59.78%
Shares Change (QoQ)	+0.88%
Owned by Insiders (%)	2.84%
Owned by Institutions (%)	36.94%
Float	20.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.65
P/TBV Ratio	4.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 46.95, with a Debt / Equity ratio of 0.01.

Current Ratio	46.95
Quick Ratio	46.66
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.01% and return on invested capital (ROIC) is -36.03%.

Return on Equity (ROE)	-53.01%
Return on Assets (ROA)	-34.72%
Return on Invested Capital (ROIC)	-36.03%
Return on Capital Employed (ROCE)	-48.70%
Revenue Per Employee	n/a
Profits Per Employee	-$2.20M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.23% in the last 52 weeks. The beta is 0.18, so BNTC's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+28.23%
50-Day Moving Average	14.36
200-Day Moving Average	13.53
Relative Strength Index (RSI)	39.68
Average Volume (20 Days)	334,163

Short Selling Information

Short Interest	1.41M
Short Previous Month	1.15M
Short % of Shares Out	4.17%
Short % of Float	6.97%
Short Ratio (days to cover)	5.92

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-45.78M
Pretax Income	-41.82M
Net Income	-41.82M
EBITDA	-45.72M
EBIT	-45.78M
Earnings Per Share (EPS)	-$1.06

Balance Sheet

The company has $94.48 million in cash and $817,000 in debt, giving a net cash position of $93.66 million or $2.77 per share.

Cash & Cash Equivalents	94.48M
Total Debt	817,000
Net Cash	93.66M
Net Cash Per Share	$2.77
Equity (Book Value)	93.60M
Book Value Per Share	3.57
Working Capital	93.05M

Cash Flow

In the last 12 months, operating cash flow was -$22.35 million and capital expenditures -$18,000, giving a free cash flow of -$22.37 million.

Operating Cash Flow	-22.35M
Capital Expenditures	-18,000
Free Cash Flow	-22.37M
FCF Per Share	-$0.66

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-59.78%
Shareholder Yield	-59.78%
Earnings Yield	-9.49%
FCF Yield	-5.08%

Analyst Forecast

The average price target for BNTC is $26.00, which is 99.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.00
Price Target Difference	99.77%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.

Last Split Date	Jul 26, 2023
Split Type	Reverse
Split Ratio	1:17

Scores

Altman Z-Score	n/a
Piotroski F-Score	2